Carratù L - Search Results

1

IgA immune response against the mycobacterial antigen A60 in patients with active pulmonary tuberculosis.

Alifano M, Sofia M, Mormile M, Micco A, Mormile AF, Del Pezzo M, Carratù L. Alifano M, et al. Among authors: carratu l. Respiration. 1996;63(5):292-7. doi: 10.1159/000196563. Respiration. 1996. PMID: 8885002

2

Increased 24-hour endothelin-1 urinary excretion in patients with chronic obstructive pulmonary disease.

Sofia M, Mormile M, Faraone S, Carratù P, Alifano M, Di Benedetto G, Carratù L. Sofia M, et al. Among authors: carratu p, carratu l. Respiration. 1994;61(5):263-8. doi: 10.1159/000196349. Respiration. 1994. PMID: 7800957

3

Increased endothelin-like immunoreactive material on bronchoalveolar lavage fluid from patients with bronchial asthma and patients with interstitial lung disease.

Sofia M, Mormile M, Faraone S, Alifano M, Zofra S, Romano L, Carratù L. Sofia M, et al. Among authors: carratu l. Respiration. 1993;60(2):89-95. doi: 10.1159/000196180. Respiration. 1993. PMID: 8341860

4

Endothelin-1 excretion in urine in active pulmonary sarcoidosis and in other interstitial lung diseases.

Sofia M, Mormile M, Faraone S, Alifano M, Carratù P, Carratù L. Sofia M, et al. Among authors: carratu p, carratu l. Sarcoidosis. 1995 Sep;12(2):118-23. Sarcoidosis. 1995. PMID: 8532958

5

Abnormalities of renal endothelin during acute exacerbation in chronic obstructive pulmonary disease.

Sofia M, Maniscalco M, Celentano L, Faraone S, Mormile M, Alifano M, Carratù L. Sofia M, et al. Among authors: carratu l. Pulm Pharmacol Ther. 2001;14(4):321-7. doi: 10.1006/pupt.2001.0303. Pulm Pharmacol Ther. 2001. PMID: 11440561

6

Transient decrease of exhaled nitric oxide after acute exposure to passive smoke in healthy subjects.

Maniscalco M, Di Mauro V, Farinaro E, Carratù L, Sofia M. Maniscalco M, et al. Among authors: carratu l. Arch Environ Health. 2002 Sep-Oct;57(5):437-40. doi: 10.1080/00039890209601434. Arch Environ Health. 2002. PMID: 12641186

7

Long-term treatment with methotrexate in patients with corticosteroid-dependent bronchial asthma.

Stanziola A, Sofia M, Mormile M, Molino A, Carratù L. Stanziola A, et al. Among authors: carratu l. Monaldi Arch Chest Dis. 1995 Apr;50(2):109-13. Monaldi Arch Chest Dis. 1995. PMID: 7613540

8

The effect of platelet-activating factor (PAF) on nasal airway resistance in healthy subjects is not mediated by nitric oxide.

Maniscalco M, Sofia M, Faraone S, Carratù L. Maniscalco M, et al. Among authors: carratu l. Allergy. 2000 Aug;55(8):757-61. doi: 10.1034/j.1398-9995.2000.00603.x. Allergy. 2000. PMID: 10955702 Clinical Trial.

9

Effect of nitric oxide inhibition on nasal airway resistance after nasal allergen challenge in allergic rhinitis.

Maniscalco M, Sofia M, Carratù L, Higenbottam T. Maniscalco M, et al. Among authors: carratu l. Eur J Clin Invest. 2001 May;31(5):462-6. doi: 10.1046/j.1365-2362.2001.00825.x. Eur J Clin Invest. 2001. PMID: 11380599

10

Exhaled nitric oxide after inhalation of isotonic and hypotonic solutions in healthy subjects.

Maniscalco M, Vatrella A, Cremona G, Carratù L, Sofia M. Maniscalco M, et al. Among authors: carratu l. Clin Sci (Lond). 2001 Dec;101(6):645-50. Clin Sci (Lond). 2001. PMID: 11724652 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

91 results

Search Page

Filters